Indications and Purposes
| 1 Indications And Usage Reyataz ® (Atazanavir) Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection For Patients 3 Months And Older Weighing At Least 5 Kg. Limitations Of Use: • Reyataz Is Not Recommended For Use In Pediatric Patients Below The Age Of 3 Months Due To The Risk Of Kernicterus. • Use Of Reyataz/ritonavir In Treatment-Experienced Patients Should Be Guided By The Number Of Baseline Primary Protease Inhibitor Resistance Substitutions [See Microbiology (12.4) ] . Reyataz Is A Protease Inhibitor Indicated For Use In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection For Patients 3 Months And Older Weighing At Least 5 Kg. (1) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Atazanavir Sulfate |
|
ZINC3941496 |